Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 725 of 885 entries
View as:

AAVCAGsCD59 for the Treatment of Wet AMD

Phase: N/A Priority: Normal
NCT ID: NCT03585556 Org: User:
Start: 09/13/18 End: 01/18/22 Due: 01/18/23

Dose Escalation Study of JNJ-54767414 (Daratumumab) in Chinese Participants With Relapsed or Refractory Multiple Myeloma Who Failed at Least 2 Prior Lines of Systemic Therapy

Phase: N/A Priority: Normal
NCT ID: NCT02852837 Org: User:
Start: 09/26/16 End: 12/13/19 Due: 12/13/20

Study of Ibrutinib (a Bruton's Tyrosine Kinase Inhibitor), Versus Temsirolimus in Patients With Relapsed or Refractory Mantle Cell Lymphoma Who Have Received at Least One Prior Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01646021 Org: User:
Start: 12/10/12 End: 12/15/16 Due: 12/15/17

An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT00488774 Org: User:
Start: 08/31/07 End: 05/31/09 Due: 05/31/10

The CANTATA-D2 Trial (CANagliflozin Treatment And Trial Analysis - DPP-4 Inhibitor Second Comparator Trial)

Phase: N/A Priority: Normal
NCT ID: NCT01137812 Org: User:
Start: 07/31/10 End: 03/31/12 Due: 03/31/13

A Study to Assess the Relative Bioavailability of 4 New Abiraterone Acetate Tablet Formulations With Respect to the Current Commercial Abiraterone Acetate Tablet Under Fasted Conditions in Healthy Male Participants

Phase: N/A Priority: Normal
NCT ID: NCT01897389 Org: User:
Start: 07/31/13 End: 09/30/13 Due: 09/30/14

A Crossover Study to Assess the Effect of Intravenous Infusion of Piperacillin/Tazobactam on the Pharmacokinetics of Orally Administered Lumicitabine (JNJ-64041575) in Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT03441529 Org: User:
Start: 02/09/18 End: 05/03/18 Due: 05/03/19

A Study to Evaluate the Effect of Intranasal Esketamine on Cognitive Functioning in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02094378 Org: User:
Start: 06/30/14 End: 08/31/14 Due: 08/31/15

Epidemiology of Treatment Resistant Depression in Taiwan

Phase: N/A Priority: Normal
NCT ID: NCT02691520 Org: User:
Start: 09/29/15 End: 02/18/16 Due: 02/18/17

A Study to Evaluate SIMPONI (Golimumab) Therapy in Children, Adolescents and Young Adults With Pre-Symptomatic Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT03298542 Org: User:
Start: 10/16/17 End: 06/01/21 Due: 06/01/22

A Study of Ustekinumab in Chinese Participants With Active Systemic Lupus Erythematosus

Phase: N/A Priority: Normal
NCT ID: NCT04060888 Org: User:
Start: 07/14/20 End: 03/31/26 Due: 03/31/27

A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Paliperidone Palmitate in Patients With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT01559272 Org: User:
Start: 02/21/08 End: 05/24/14 Due: 05/24/15

A Study of Nipocalimab in Reducing the Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)

Phase: N/A Priority: Normal
NCT ID: NCT06449651 Org: User:
Start: 11/11/24 End: 12/11/29 Due: 12/11/30

A Study to Investigate Evoked Potentials as Markers of Ketamine-induced Cortical Plasticity in Patients With Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01957410 Org: User:
Start: 02/28/14 End: 09/30/15 Due: 09/30/16

A Study in Belgian Children Hospitalized With Respiratory Syncytial Virus Related Acute Respiratory Infections

Phase: N/A Priority: Normal
NCT ID: NCT02133092 Org: User:
Start: 12/31/13 End: 01/31/15 Due: 01/31/16

A Study of the MALT1 Inhibitor JNJ-67856633 and Ibrutinib in Combination in B-cell NHL and CLL

Phase: N/A Priority: Normal
NCT ID: NCT04876092 Org: User:
Start: 07/28/21 End: 02/13/25 Due: 02/13/26

A Study to Assess the Effects of Itraconazole and Etravirine on JNJ-64417184 in Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT04208373 Org: User:
Start: 12/20/19 End: 03/10/20 Due: 03/10/21

Pharmacokinetic Study of Intranasal Esketamine and Its Effects on the Pharmacokinetics of Orally-Administered Midazolam and Bupropion in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT02568176 Org: User:
Start: 10/31/15 End: 02/29/16 Due: 02/28/17

A Study of the Safety and Pharmacokinetics of an Anti-Inflammatory Therapeutic Antibody (MABp1) in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01427699 Org: User:
Start: 06/30/11 End: - Due: -

A Study to Assess Different Diagnostic Criteria of Chronic Constipation in Asia

Phase: N/A Priority: Normal
NCT ID: NCT01880294 Org: User:
Start: 03/18/13 End: 12/14/13 Due: 12/14/14

A Study of JNJ-80202135 in Healthy Chinese Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT05151692 Org: User:
Start: 05/30/22 End: 09/09/22 Due: 09/09/23

Study of Efficacy, Safety of Fulranumab Adjunctive Use in OA of Hip or Knee, PAI3001

Phase: N/A Priority: Normal
NCT ID: NCT02336685 Org: User:
Start: 07/07/15 End: 09/16/16 Due: 09/16/17

A Study to Evaluate the Effectiveness and Safety of Paliperidone Palmitate in Subjects With Acute Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT01527305 Org: User:
Start: 06/22/12 End: 12/31/13 Due: 12/31/14

A Study to Assess Interaction Between JNJ-64417184 and JNJ-53718678 After Single and Multiple Dosing in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT04090086 Org: User:
Start: 09/16/19 End: 12/10/19 Due: 12/10/20

A Single and Multiple Ascending Dose Study of Subcutaneously Administered JNJ-75220795

Phase: N/A Priority: Normal
NCT ID: NCT04844450 Org: User:
Start: 04/29/21 End: 03/31/23 Due: 03/31/24